| PERIOD ENDING | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | | Total Revenue | 450,700 | 408,900 | 403,700 | 433,400 | | Cost of Revenue | 250,400 |
-
| 493,300 |
-
| | | Gross Profit | 200,300 | 408,900 | (89,600) | 433,400 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | (5,700) | 232,600 | (246,400) | 230,800 | | Non Recurring | 3,100 | 11,800 | 200 | (1,800) | | Others | 15,700 | 15,600 | 31,200 | 14,600 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 187,200 | 148,900 | 125,400 | 189,800 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (14,700) | 4,200 | (44,800) | 20,800 | | Earnings Before Interest And Taxes | 172,500 | 153,100 | 80,600 | 210,600 | | Interest Expense | (2,100) | 11,500 | (43,700) | 26,700 | | Income Before Tax | 174,600 | 141,600 | 124,300 | 183,900 | | Income Tax Expense | 63,600 | 50,500 | 35,600 | 70,900 | | Minority Interest | 900 | (900) |
-
|
-
| | | | Net Income From Continuing Ops | 111,900 | 90,200 | 88,700 | 113,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 111,900 | 90,200 | 88,700 | 113,000 | | Preferred Stock And Other Adjustments | (2,600) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $109,300 | $90,200 | $88,700 | $113,000 |
|
2.03% Nasdaq 
Income Statement
